Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
MFAP4,Microfibril-associated glycoprotein 4,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,Inverse variance weighted,19,1.06 [1.01-1.11],0.0147664594369854
MFAP4,Microfibril-associated glycoprotein 4,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,Inverse variance weighted,19,1.36 [0.52-3.61],0.531433084604759
MFAP4,Microfibril-associated glycoprotein 4,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",Inverse variance weighted,19,1.01 [0.90-1.14],0.838700322681775
MFAP4,Microfibril-associated glycoprotein 4,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",Inverse variance weighted,19,0.72 [0.55-0.94],0.0143825600875749
MFAP4,Microfibril-associated glycoprotein 4,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,Inverse variance weighted,19,0.99 [0.90-1.09],0.84501664298915
MFAP4,Microfibril-associated glycoprotein 4,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,19,1.08 [0.98-1.20],0.129459013376211
MFAP4,Microfibril-associated glycoprotein 4,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,Inverse variance weighted,19,1.12 [0.66-1.90],0.684645475198526
MFAP4,Microfibril-associated glycoprotein 4,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,Inverse variance weighted,19,0.96 [0.81-1.13],0.608165421215838
MFAP4,Microfibril-associated glycoprotein 4,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",Inverse variance weighted,19,0.81 [0.64-1.02],0.0751182270956018
MFAP4,Microfibril-associated glycoprotein 4,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,Inverse variance weighted,19,0.88 [0.74-1.04],0.134078547195539
MFAP4,Microfibril-associated glycoprotein 4,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,Inverse variance weighted,19,1.14 [0.75-1.72],0.54707457382109
MFAP4,Microfibril-associated glycoprotein 4,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,Inverse variance weighted,19,1.03 [0.85-1.25],0.751014677316382
MFAP4,Microfibril-associated glycoprotein 4,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,19,1.08 [0.98-1.19],0.100937786207425
MFAP4,Microfibril-associated glycoprotein 4,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,Inverse variance weighted,19,0.95 [0.80-1.14],0.606583749044147
MFAP4,Microfibril-associated glycoprotein 4,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,Inverse variance weighted,19,1.10 [0.85-1.42],0.474143912444495
MFAP4,Microfibril-associated glycoprotein 4,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,Inverse variance weighted,19,1.05 [1.01-1.10],0.0174239560615998
MFAP4,Microfibril-associated glycoprotein 4,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,Inverse variance weighted,19,1.22 [0.52-2.83],0.648164140849793
MFAP4,Microfibril-associated glycoprotein 4,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,Inverse variance weighted,19,1.11 [0.91-1.35],0.321943212368525
MFAP4,Microfibril-associated glycoprotein 4,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,Inverse variance weighted,19,1.05 [0.86-1.30],0.621793187911281
MFAP4,Microfibril-associated glycoprotein 4,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",Inverse variance weighted,19,0.92 [0.78-1.08],0.312888451100165
MFAP4,Microfibril-associated glycoprotein 4,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",Inverse variance weighted,19,0.90 [0.73-1.10],0.299604722528172
MFAP4,Microfibril-associated glycoprotein 4,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,19,1.04 [0.96-1.12],0.306335494464228
MFAP4,Microfibril-associated glycoprotein 4,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",Inverse variance weighted,19,0.98 [0.89-1.09],0.737626764454018
MFAP4,Microfibril-associated glycoprotein 4,Chapter IX Diseases of the circulatory system,Cardiac arrest,Inverse variance weighted,19,1.10 [0.90-1.34],0.359208049514626
MFAP4,Microfibril-associated glycoprotein 4,Chapter IX Diseases of the circulatory system,Cardiomyopathy,Inverse variance weighted,19,1.05 [0.93-1.18],0.434373301184272
MFAP4,Microfibril-associated glycoprotein 4,Chapter IX Diseases of the circulatory system,Conduction disorders,Inverse variance weighted,19,0.99 [0.86-1.13],0.829093294944538
MFAP4,Microfibril-associated glycoprotein 4,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,19,1.04 [0.97-1.11],0.269145034584688
MFAP4,Microfibril-associated glycoprotein 4,Chapter IX Diseases of the circulatory system,"Hypertension, essential",Inverse variance weighted,19,1.05 [1.00-1.10],0.056734482622739
MFAP4,Microfibril-associated glycoprotein 4,Chapter IX Diseases of the circulatory system,Hypertension,Inverse variance weighted,19,1.05 [1.00-1.10],0.0402745273838778
MFAP4,Microfibril-associated glycoprotein 4,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",Inverse variance weighted,19,1.08 [0.60-1.96],0.798489995276921
MFAP4,Microfibril-associated glycoprotein 4,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,Inverse variance weighted,19,1.12 [0.81-1.55],0.503790506005221
MFAP4,Microfibril-associated glycoprotein 4,Chapter IX Diseases of the circulatory system,Left bundle-branch block,Inverse variance weighted,19,1.09 [0.88-1.35],0.408836020136747
MFAP4,Microfibril-associated glycoprotein 4,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,Inverse variance weighted,19,1.00 [0.76-1.31],0.989831932259644
MFAP4,Microfibril-associated glycoprotein 4,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,Inverse variance weighted,19,1.37 [1.02-1.85],0.0393534728953334
MFAP4,Microfibril-associated glycoprotein 4,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,Inverse variance weighted,19,1.02 [0.84-1.24],0.851074684647226
MFAP4,Microfibril-associated glycoprotein 4,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,Inverse variance weighted,19,1.12 [1.01-1.23],0.0286661202985979
MFAP4,Microfibril-associated glycoprotein 4,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,Inverse variance weighted,19,0.85 [0.58-1.24],0.393224852886027
MFAP4,Microfibril-associated glycoprotein 4,Chapter IX Diseases of the circulatory system,Secondary right heart disease,Inverse variance weighted,19,0.96 [0.72-1.26],0.748096151323773
MFAP4,Microfibril-associated glycoprotein 4,Chapter IX Diseases of the circulatory system,Oesophageal varices,Inverse variance weighted,19,0.96 [0.72-1.27],0.767089081763991
MFAP4,Microfibril-associated glycoprotein 4,Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,19,0.99 [0.94-1.04],0.705699987552492
MFAP4,Microfibril-associated glycoprotein 4,Chapter X Diseases of the respiratory system,Other diseases of pleura,Inverse variance weighted,19,0.96 [0.88-1.05],0.401805054783806
MFAP4,Microfibril-associated glycoprotein 4,Chapter X Diseases of the respiratory system,Pleural effusion,Inverse variance weighted,19,0.96 [0.84-1.10],0.544888731157641
MFAP4,Microfibril-associated glycoprotein 4,Chapter X Diseases of the respiratory system,Pulmonary oedema,Inverse variance weighted,19,0.83 [0.55-1.25],0.376919465656712
MFAP4,Microfibril-associated glycoprotein 4,Chapter XI Diseases of the digestive system,Alcoholic liver disease,Inverse variance weighted,19,0.95 [0.80-1.13],0.567745347479057
MFAP4,Microfibril-associated glycoprotein 4,Chapter XI Diseases of the digestive system,Other diseases of liver,Inverse variance weighted,19,0.91 [0.76-1.09],0.292474889493113
MFAP4,Microfibril-associated glycoprotein 4,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,Inverse variance weighted,19,0.72 [0.58-0.89],0.0025840153526887
MFAP4,Microfibril-associated glycoprotein 4,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",Inverse variance weighted,19,0.99 [0.74-1.33],0.953143578661236
MFAP4,Microfibril-associated glycoprotein 4,Chapter XI Diseases of the digestive system,Diseases of liver,Inverse variance weighted,19,0.91 [0.82-1.01],0.0679300035514323
MFAP4,Microfibril-associated glycoprotein 4,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,Inverse variance weighted,19,0.84 [0.67-1.06],0.145667115174672
MFAP4,Microfibril-associated glycoprotein 4,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,Inverse variance weighted,19,0.78 [0.63-0.96],0.0193510712232735
MFAP4,Microfibril-associated glycoprotein 4,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",Inverse variance weighted,19,1.18 [1.02-1.37],0.0305710114542319
MFAP4,Microfibril-associated glycoprotein 4,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,Inverse variance weighted,19,0.90 [0.75-1.08],0.249363080653594
MFAP4,Microfibril-associated glycoprotein 4,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,19,0.98 [0.87-1.11],0.778990518881474
MFAP4,Microfibril-associated glycoprotein 4,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,Inverse variance weighted,19,1.17 [0.88-1.56],0.287147934043058
MFAP4,Microfibril-associated glycoprotein 4,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,19,1.08 [0.98-1.18],0.139329199928601
MFAP4,Microfibril-associated glycoprotein 4,Chapter XIV Diseases of the genitourinary system,Dialysis,Inverse variance weighted,19,1.10 [0.81-1.48],0.541582554702864
MFAP4,Microfibril-associated glycoprotein 4,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,Inverse variance weighted,19,0.99 [0.85-1.16],0.89189807620329
MFAP4,Microfibril-associated glycoprotein 4,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,19,1.05 [0.99-1.10],0.079467830092674
MFAP4,Microfibril-associated glycoprotein 4,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,Inverse variance weighted,19,1.10 [0.92-1.31],0.29861714529727
MFAP4,Microfibril-associated glycoprotein 4,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,Inverse variance weighted,19,1.07 [0.88-1.30],0.514365063665175
